Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Susac’s Syndrome: Confusion, Expressive Aphasia, Gait Instability

Candace H. Feldman, MD, MPH, Gwendolyn Kane-Wagner, MD  |  Issue: March 2012  |  March 8, 2012

Additional information about his history was obtained. He worked for a pharmaceutical company and as a personal trainer. He denied smoking, illicit drugs, heavy alcohol consumption, or recent travel. His family history was notable for a father with multiple transient ischemic attacks and a maternal uncle with multiple sclerosis (MS). He had no family history of rheumatologic diseases.

Further laboratory tests were sent (see Table 2). Electroencephalography (EEG) revealed generalized bursts of slowing, consistent with a mild to moderate encephalopathy of toxic, metabolic, or anoxic etiology with no evidence of seizure activity. A repeat MRI of his brain was performed (see Figure 1), which showed innumerable small foci of restricted diffusion scattered over the cerebrum, cerebellum, and brainstem, increased from the prior MRI, with some cortical lesions, but primarily involving the white matter, notably the corpus callosum. The foci were hyperintense on FLAIR imaging and there was persistent leptomeningeal enhancement. There was no evidence of acute infarction or hemorrhage.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

click for large version
Table 2: Laboratory Tests—Serum

Diagnosis

The differential diagnosis at this point was broad. Infectious etiologies were first investigated. Viral etiologies, particularly herpes simplex virus type 1 (HSV-1) encephalitis, characterized by fever, headache, focal neurologic findings, and impaired consciousness, were considered.1 However, SG did not have fevers or a headache, and CSF polymerase chain reaction (PCR), which has very high sensitivity and specificity for detection of HSV-1, was negative.2 Further tests for other infections that can manifest with central nervous system (CNS) involvement, including human immunodeficiency virus (HIV), human T-lymphotropic virus 1 and 2, syphilis, Lyme disease, hepatitis B and C, and tuberculosis, were negative. Toxic ingestions and illicit drugs were also investigated and both his toxicology screen and his serum alcohol level were negative.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Primary neurologic diseases were also considered. Given his initial viral prodrome, the increase in CSF protein, and his MRI findings of multifocal white-matter lesions, post-viral acute disseminated encephalomyelitis (ADEM) was a concern. The possibility of MS was discussed, however his brain MRI findings did not appear to be consistent with this diagnosis, and an MRI of his cervical and thoracic spine showed no evidence of demyelination. Two well-defined gamma-restriction bands were seen in both his CSF and his serum, but this is a nonspecific finding, not suggestive of MS. Creutzfeldt-Jakob disease was considered, given his memory loss and psychiatric symptoms; however, he had no evidence of myoclonus, and did not exhibit rapid mental deterioration.3 Malignancy, especially lymphoma, was plausible given the leptomeningeal enhancement seen on his MRI; CSF cytology, however, was negative for malignant cells.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:Career DevelopmentConditionsEducation & TrainingOther Rheumatic ConditionsProfessional Topics Tagged with:ANA titerDiagnostic Criteriadrugimagingintravenous immunoglobulinsPathogenesispatient careprednisonerheumatologistTreatment

Related Articles

    Watch Those Eyes

    December 1, 2007

    What you need to know about Uveitis in Rheumatic Diseases

    Hydroxychloroquine Retinopathy Still Alive and Well

    May 16, 2011

    How rheumatologists are affected by new guidelines from ophthalmology

    Ocular Disease Monitoring Critical to Avoid Retinal Toxicity from Hydroxychloroquine

    November 16, 2016

    Both due to its efficacy and favorable side effect profile when compared with alternative drugs for rheumatologic conditions, hydroxychloroquine is an important agent in rheumatologists’ armamentarium. However, one barrier to hydroxychloroquine use can be its effects on the eye (also see “Revised Retinopathy Screening Guidelines,”). Ocular side effects of hydroxychloroquine can include impact on the…

    APS: What Rheumatologists Should Know about Hughes Syndrome

    February 17, 2016

    The problem that dogs the work of all of those treating patients with antiphospholipid syndrome (APS) is the apparent lack of knowledge of the syndrome, both by the general public, as well as by swaths of the medical fraternity. Perhaps it was ever thus—a syndrome less than 40 years old could be described as new,…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences